Does the immune system see tumors as foreign or self?

Research output: Contribution to journalArticle

Abstract

Given the vast number of genetic and epigenetic changes associated with carcinogenesis, it is clear that tumors express many neoantigens. A central question in cancer immunology is whether recognition of tumor antigens by the immune system leads to activation (i.e., surveillance) or tolerance. Paradoxically, while strong evidence exists that specific immune surveillance systems operate at early stages of tumorigenesis, established tumors primarily induce immune tolerance. A unifying hypothesis posits that the fundamental processes of cancer progression, namely tissue invasion and metastasis, are inherently proinflammatory and thus activating for innate and adaptive antitumor immunity. To elude immune surveillance, tumors must develop mechanisms that block the elaboration and sensing of proinflammatory danger signals, thereby shifting the balance from activation to tolerance induction. Elucidation of these mechanisms provides new strategies for cancer immunotherapy.

Original languageEnglish (US)
Pages (from-to)807-839
Number of pages33
JournalAnnual Review of Immunology
Volume21
DOIs
StatePublished - 2003

Fingerprint

Immune System
Neoplasms
Carcinogenesis
Immune Tolerance
Adaptive Immunity
Neoplasm Antigens
Allergy and Immunology
Epigenomics
Immunotherapy
Neoplasm Metastasis

Keywords

  • Immune escape
  • Immune surveillance
  • NKG2D
  • Tumor tolerance

ASJC Scopus subject areas

  • Immunology

Cite this

Does the immune system see tumors as foreign or self? / Pardoll, Andrew Mark.

In: Annual Review of Immunology, Vol. 21, 2003, p. 807-839.

Research output: Contribution to journalArticle

@article{e65a7a092f8a476ba80db11182abcee2,
title = "Does the immune system see tumors as foreign or self?",
abstract = "Given the vast number of genetic and epigenetic changes associated with carcinogenesis, it is clear that tumors express many neoantigens. A central question in cancer immunology is whether recognition of tumor antigens by the immune system leads to activation (i.e., surveillance) or tolerance. Paradoxically, while strong evidence exists that specific immune surveillance systems operate at early stages of tumorigenesis, established tumors primarily induce immune tolerance. A unifying hypothesis posits that the fundamental processes of cancer progression, namely tissue invasion and metastasis, are inherently proinflammatory and thus activating for innate and adaptive antitumor immunity. To elude immune surveillance, tumors must develop mechanisms that block the elaboration and sensing of proinflammatory danger signals, thereby shifting the balance from activation to tolerance induction. Elucidation of these mechanisms provides new strategies for cancer immunotherapy.",
keywords = "Immune escape, Immune surveillance, NKG2D, Tumor tolerance",
author = "Pardoll, {Andrew Mark}",
year = "2003",
doi = "10.1146/annurev.immunol.21.120601.141135",
language = "English (US)",
volume = "21",
pages = "807--839",
journal = "Annual Review of Immunology",
issn = "0732-0582",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Does the immune system see tumors as foreign or self?

AU - Pardoll, Andrew Mark

PY - 2003

Y1 - 2003

N2 - Given the vast number of genetic and epigenetic changes associated with carcinogenesis, it is clear that tumors express many neoantigens. A central question in cancer immunology is whether recognition of tumor antigens by the immune system leads to activation (i.e., surveillance) or tolerance. Paradoxically, while strong evidence exists that specific immune surveillance systems operate at early stages of tumorigenesis, established tumors primarily induce immune tolerance. A unifying hypothesis posits that the fundamental processes of cancer progression, namely tissue invasion and metastasis, are inherently proinflammatory and thus activating for innate and adaptive antitumor immunity. To elude immune surveillance, tumors must develop mechanisms that block the elaboration and sensing of proinflammatory danger signals, thereby shifting the balance from activation to tolerance induction. Elucidation of these mechanisms provides new strategies for cancer immunotherapy.

AB - Given the vast number of genetic and epigenetic changes associated with carcinogenesis, it is clear that tumors express many neoantigens. A central question in cancer immunology is whether recognition of tumor antigens by the immune system leads to activation (i.e., surveillance) or tolerance. Paradoxically, while strong evidence exists that specific immune surveillance systems operate at early stages of tumorigenesis, established tumors primarily induce immune tolerance. A unifying hypothesis posits that the fundamental processes of cancer progression, namely tissue invasion and metastasis, are inherently proinflammatory and thus activating for innate and adaptive antitumor immunity. To elude immune surveillance, tumors must develop mechanisms that block the elaboration and sensing of proinflammatory danger signals, thereby shifting the balance from activation to tolerance induction. Elucidation of these mechanisms provides new strategies for cancer immunotherapy.

KW - Immune escape

KW - Immune surveillance

KW - NKG2D

KW - Tumor tolerance

UR - http://www.scopus.com/inward/record.url?scp=0042470540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042470540&partnerID=8YFLogxK

U2 - 10.1146/annurev.immunol.21.120601.141135

DO - 10.1146/annurev.immunol.21.120601.141135

M3 - Article

VL - 21

SP - 807

EP - 839

JO - Annual Review of Immunology

JF - Annual Review of Immunology

SN - 0732-0582

ER -